-+ 0.00%
-+ 0.00%
-+ 0.00%

SELLAS LIFE SCIENCES GROUP: IDMC HAS RECOMMENDED THAT TRIAL CONTINUE WITHOUT MODIFICATIONS

Reuters·01/23/2025 13:10:28

Please log in to view news